X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Human Vaccines & Immunotherapeutics

期刊標題檢索 HUM VACCINES 最新評論: Fast. First review in 40 days. 14 days for second review. Awesome. (2014-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Human Vaccines & Immunotherapeutics]您好,您是該頁面的第 24479 位訪客。

期刊簡介
期刊名稱Human Vaccines & Immunotherapeutics Human Vaccines & Immunotherapeutics
LetPub Score
5.3
50 ratings
Rate

Reputation
6.6

Influence
4.0

Speed
7.0

期刊簡稱HUM VACCINES
ISSN1554-8600
h-indexN.A.
CiteScoreN.A.
自引率 (2023-2024)9.80%自引率趨勢
掲載範囲
(formerly Human Vaccines; issn 1554-8619)

Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.

Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.
官方網站http://www.tandfonline.com/loi/khvi20
在線稿件提交https://www.editorialmanager.com/HV
開放訪問No
出版商TAYLOR & FRANCIS INC
主題領域BIOTECHNOLOGY & APPLIED MICROBIOLOGY
出版國/地區UNITED STATES
發行頻率月刊
創刊年2005
每年文章數452每年文章數趨勢
黃金OA百分比80.48%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOTECHNOLOGY & APPLIED MICROBIOLOGYSCIEQ245/174
IMMUNOLOGYSCIEQ274/181
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1554-8600%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【Human Vaccines & Immunotherapeutics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Science ImmunologyH-index: 0

    CiteScore: 32.90
    Journal of Allergy and Clinical Immunology-In PracticeH-index: 40

    CiteScore: 11.10
    Cancer Immunology ResearchH-index: 62

    CiteScore: 15.60
    npj VaccinesH-index: 8

    CiteScore: 11.90
    OncoImmunologyH-index: 58

    CiteScore: 12.80
    OncoImmunologyH-index: 49

    CiteScore: 12.80
    ALLERGOLOGY INTERNATIONALH-index: 45

    CiteScore: 12.60
    HLAH-index: 93

    CiteScore: 3.00
    Immunity & AgeingH-index: 38

    CiteScore: 10.20
    Clinical and Translational AllergyH-index: 28

    CiteScore: 7.50
    學科內最受檢索的期刊 頁面查看次數
    Journal of Inflammation Research74002
    Cancer Immunology Research57105
    OncoImmunology54803
    OncoImmunology50217
    Science Immunology39869
    npj Vaccines29222
    Human Vaccines & Immunotherapeutics24445
    Endocrine Metabolic & Immune Disorders-Drug Targets20779
    Journal of Allergy and Clinical Immunology-In Practice18702
    Allergy Asthma & Immunology Research18484
  •  

    Human Vaccines & Immunotherapeutics Human Vaccines & Immunotherapeutics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Human Vaccines & Immunotherapeutics] 的評論撰寫評論
作者: stone_wang1986@126.com


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2014-12-30 15:10:12 評論於
Fast. First review in 40 days. 14 days for second review. Awesome.

(2) 讚! | stone_wang1986@126.com

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Human Vaccines & Immunotherapeutics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*